| Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised … T Powles, P Tomczak, SH Park, B Venugopal, T Ferguson, ... The lancet oncology 23 (9), 1133-1144, 2022 | 175 | 2022 |
| Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus K Numakura, S Satoh, N Tsuchiya, Y Horikawa, T Inoue, H Kakinuma, ... Transplantation 80 (10), 1419-1424, 2005 | 143 | 2005 |
| Impact of the CYP3A4*1G polymorphism and its combination with CYP3A5 genotypes on tacrolimus pharmacokinetics in renal transplant patients M Miura, S Satoh, H Kagaya, M Saito, K Numakura, N Tsuchiya, ... Pharmacogenomics 12 (7), 977-984, 2011 | 87 | 2011 |
| A high‐fat diet enhances proliferation of prostate cancer cells and activates MCP‐1/CCR2 signaling M Huang, S Narita, K Numakura, H Tsuruta, M Saito, T Inoue, Y Horikawa, ... The Prostate 72 (16), 1779-1788, 2012 | 79 | 2012 |
| Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome M Huang, S Narita, N Tsuchiya, Z Ma, K Numakura, T Obara, H Tsuruta, ... Carcinogenesis 32 (11), 1589-1596, 2011 | 72 | 2011 |
| Comparison of pharmacokinetics and pharmacogenetics of once-and twice-daily tacrolimus in the early stage after renal transplantation T Niioka, S Satoh, H Kagaya, K Numakura, T Inoue, M Saito, S Narita, ... Transplantation 94 (10), 1013-1019, 2012 | 70 | 2012 |
| Genomic profiling of renal cell carcinoma in patients with end‐stage renal disease T Inoue, K Matsuura, T Yoshimoto, LT Nguyen, Y Tsukamoto, C Nakada, ... Cancer Science 103 (3), 569-576, 2012 | 54 | 2012 |
| Circadian pharmacokinetics of mycophenolic acid and implication of genetic polymorphisms for early clinical events in renal transplant recipients S Satoh, H Tada, M Murakami, N Tsuchiya, Z Li, K Numakura, M Saito, ... Transplantation 82 (4), 486-493, 2006 | 53 | 2006 |
| Correlations between pretransplant dialysis duration, bladder capacity, and prevalence of vesicoureteral reflux to the graft T Inoue, S Satoh, M Saito, K Numakura, H Tsuruta, T Obara, S Narita, ... Transplantation 92 (3), 311-315, 2011 | 51 | 2011 |
| Lack of tacrolimus circadian pharmacokinetics and CYP3A5 pharmacogenetics in the early and maintenance stages in Japanese renal transplant recipients S Satoh, H Kagaya, M Saito, T Inoue, M Miura, K Inoue, K Numakura, ... British journal of clinical pharmacology 66 (2), 207-214, 2008 | 51 | 2008 |
| Hyperuricemia at 1 year after renal transplantation, its prevalence, associated factors, and graft survival K Numakura, S Satoh, N Tsuchiya, M Saito, S Maita, T Obara, H Tsuruta, ... Transplantation 94 (2), 145-151, 2012 | 46 | 2012 |
| Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine … S Narita, N Tsuchiya, T Kumazawa, S Maita, K Numakura, T Obara, ... World Journal of Surgical Oncology 10, 1-6, 2012 | 45 | 2012 |
| Diet-induced alteration of fatty acid synthase in prostate cancer progression M Huang, A Koizumi, S Narita, T Inoue, N Tsuchiya, H Nakanishi, ... Oncogenesis 5 (2), e195-e195, 2016 | 44 | 2016 |
| The impact of obesity and adiponectin signaling in patients with renal cell carcinoma: A potential mechanism for the “obesity paradox” R Ito, S Narita, M Huang, T Nara, K Numakura, K Takayama, H Tsuruta, ... PLoS One 12 (2), e0171615, 2017 | 43 | 2017 |
| Effects of functional genetic polymorphisms in the CYP19A1 gene on prostate cancer risk and survival S Kanda, N Tsuchiya, S Narita, T Inoue, M Huang, S Chiba, S Akihama, ... International Journal of Cancer 136 (1), 74-82, 2015 | 40 | 2015 |
| Fatty acid binding protein 4 enhances prostate cancer progression by upregulating matrix metalloproteinases and stromal cell cytokine production M Huang, S Narita, T Inoue, A Koizumi, M Saito, H Tsuruta, K Numakura, ... Oncotarget 8 (67), 111780, 2017 | 39 | 2017 |
| Incidence and location of positive surgical margin among open, laparoscopic and robot-assisted radical prostatectomy in prostate cancer patients: a single institutional analysis A Koizumi, S Narita, T Nara, K Takayama, S Kanda, K Numakura, ... Japanese journal of clinical oncology 48 (8), 765-770, 2018 | 37 | 2018 |
| Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101 M Uemura, Y Tomita, H Miyake, S Hatakeyama, H Kanayama, ... Cancer science 111 (3), 907-923, 2020 | 35 | 2020 |
| Pharmaceutical and genetic determinants for interindividual differences of tacrolimus bioavailability in renal transplant recipients T Niioka, H Kagaya, M Miura, K Numakura, M Saito, T Inoue, T Habuchi, ... European journal of clinical pharmacology 69, 1659-1665, 2013 | 34 | 2013 |
| Risk factors for sorafenib-induced high-grade skin rash in Japanese patients with advanced renal cell carcinoma N Tsuchiya, S Narita, T Inoue, N Hasunuma, K Numakura, Y Horikawa, ... Anti-cancer drugs 24 (3), 310-314, 2013 | 32 | 2013 |
